Glycaemic Control and Its Associated Factors in Chinese Adults with Type 1 Diabetes Mellitus

Li Liu,Daizhi Yang,Yan Zhang,Shuo Lin,Xueying Zheng,Shaoda Lin,Lishu Chen,Xiuwei Zhang,Lu Li,Ganxiong Liang,Bin Yao,Jinhua Yan,Jianping Weng
DOI: https://doi.org/10.1002/dmrr.2716
2015-01-01
Diabetes/Metabolism Research and Reviews
Abstract:Background Glycaemic control is a great challenge in the management of type 1 diabetes mellitus (T1DM). There is limited data concerning glycaemic control among adults with T1DM. We used data from the Guangdong T1DM Translational Medicine Study to evaluate glycaemic control and its associated factors in Chinese adults with T1DM.Methods This cross-sectional analysis included 827 participants who were 18 years of age or older and had been living with T1DM for at least 1 year. Participants with HbA(1c) levels <7% were compared against those with HbA(1c) levels >= 7%. A multivariate logistic regression model was used to examine factors associated with glycaemic control.Results Among the 827 participants, the mean age was 34.2 similar to 12.1 years and the median (interquartile range) duration of diabetes was 6.1 (3.4, 10.4) years. The median HbA(1c) level was 8.5% (7.5%, 10.2%). Only one-fifth of participants had HbA(1c) levels < 7%. Insufficient glycaemic control (HbA(1c) = 7%) was strongly associated with infrequent self-monitoring of blood glucose (OR=1.21, 95% CI 1.14 similar to 1.29, p=0.000), high insulin dose (OR=1.27, 95% CI 1.07 similar to 1.52, p=0.006), smoking (OR=3.11, 95% CI 1.44 similar to 6.72, p=0.004), low-frequency clinical visits (OR=2.74, 95% CI 1.47 similar to 5.10, p=0.001), the presence of diabetic autoantibodies (OR=1.63, 95% CI 1.07 similar to 2.48, p=0.022) and low fasting C-peptide (FCP) levels (OR=1.21, 95% CI 1.01 similar to 1.46, p=0.049) after adjustment for age at disease onset, education level, household income and diet control.Conclusions Most adult patients with T1DM did not achieve the HbA(1c) target. Identifying determinants for glycaemic control provides us valuable information to improve glycaemic control in these patients. Copyright (C) 2015 John Wiley & Sons, Ltd.
What problem does this paper attempt to address?